世界の補助人工心臓(VAD)市場2021年-2031年:製品別(左心室補助装置(LVAD)、右心室補助装置(RVAD)、両室節補助装置(BIVAD))、用途別(移植へのブリッジ(BTT)、長期在宅補助人工心臓治療(DT)、回復へのブリッジ(BTR)、移植登録へのブリッジ(BTC)療法)、デザイン別(経皮的補助人工心臓、埋め込み可能型補助人工心臓)、年齢別(成人、小児科)

【英語タイトル】Ventricular Assist Devices Market By Product (Left Ventricular Assist Devices (LVADs), Right Ventricular Assist Devices (RVADs), Biventricular Assist Devices (BIVADs)), By Application (Bridge-To-Transplant (BTT), Destination Therapy, Bridge-To-Recovery (BTR), Bridge To Candidacy Therapy), By Design (Transcutaneous Ventricular Assist Devices, Implantable Ventricular Assist Devices), By Age (Adults, Pediatrics): Global Opportunity Analysis and Industry Forecast, 2021-2031

Allied Market Researchが出版した調査資料(ALD23MY043)・商品コード:ALD23MY043
・発行会社(調査会社):Allied Market Research
・発行日:2023年2月
・ページ数:316
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後24時間以内)
・調査対象地域:グローバル
・産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD5,730 ⇒換算¥848,040見積依頼/購入/質問フォーム
5 UserUSD6,450 ⇒換算¥954,600見積依頼/購入/質問フォーム
Enterprise UserUSD9,600 ⇒換算¥1,420,800見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

Allied Market Research社は、2021年には1,338.53百万ドルであった世界の補助人工心臓(VAD)市場規模が2031年には2,880.66百万ドルへ上り、予測期間中(2022年~2031年)に年平均7.9%成長すると予測しています。本書では、補助人工心臓(VAD)の世界市場を調査対象とし、イントロダクション、エグゼクティブサマリー、市場概要、製品別(左心室補助装置(LVAD)、右心室補助装置(RVAD)、両室節補助装置(BIVAD))分析、用途別(移植へのブリッジ(BTT)、長期在宅補助人工心臓治療(DT)、回復へのブリッジ(BTR)、移植登録へのブリッジ(BTC)療法)分析、デザイン別(経皮的補助人工心臓、埋め込み可能型補助人工心臓)分析、年齢別(成人、小児科)分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米/中東・アフリカ)分析、競争状況、企業情報などの項目をまとめました。また、市場調査の対象企業には、Evaheart, Inc.、Abiomed, Inc.、Abbott Laboratories、CH Biomedical, Inc.、Carmat SA、Calon Cardio-Technology Ltd、Bivacor Inc.、LivaNova PLC、Berlin Heart GmbH、Fineheart、AdjuCor GmbH、NuPulseCV, Inc.、Jarvik Heart, Inc.などが含まれています。
・イントロダクション
・エグゼクティブサマリー
・市場概要
・世界の補助人工心臓(VAD)市場規模:製品別
- 左心室補助装置(LVAD)の市場規模
- 右心室補助装置(RVAD)の市場規模
- 両室節補助装置(BIVAD)の市場規模
・世界の補助人工心臓(VAD)市場規模:用途別
- 移植へのブリッジ(BTT)における市場規模
- 長期在宅補助人工心臓治療(DT)における市場規模
- 回復へのブリッジ(BTR)における市場規模
- 移植登録へのブリッジ(BTC)療法における市場規模
・世界の補助人工心臓(VAD)市場規模:デザイン別
- 経皮的補助人工心臓の市場規模
- 埋め込み可能型補助人工心臓の市場規模
・世界の補助人工心臓(VAD)市場規模:年齢別
- 成人における市場規模
- 小児科における市場規模
・世界の補助人工心臓(VAD)市場規模:地域別
- 北米の補助人工心臓(VAD)市場規模
- ヨーロッパの補助人工心臓(VAD)市場規模
- アジア太平洋の補助人工心臓(VAD)市場規模
- 中南米/中東・アフリカの補助人工心臓(VAD)市場規模
・競争状況
・企業情報

補助人工心臓(VAD)市場は2021年に13億3,853万ドル、2031年には28億8,066万ドルに達すると予測され、2022年から2031年までの年平均成長率は7.9%となる見込みです。

補助人工心臓(VAD)は、機械的循環補助装置(MCS)としても知られ、心臓のポンプ機能をサポートします。患者の体内を流れる血液量を増やすために使用されます。これにより、進行した心不全の患者さんは、再び生活の質を向上させることができます。補助人工心臓は右心室または左心室のいずれかを補助しますが、主に左心室に植え込みます。左心室に留置する場合は、左心補助循環装置(LVAD)と呼ばれます。
補助人工心臓は心不全の治療によく用いられます。補助人工心臓の移植は、移植する機能によって一時的なものと永続的なものがあります。一時的に植え込まれるのは、心臓移植を待っている患者さんや、心臓が自分で血液を送り出せるようになるまで回復を助ける治療を受けている患者さんです。
一方、補助人工心臓は、心室機能に異常がある患者さんの心臓を流れる血液を適切に確保するために永久的に植え込まれます。このような心不全治療への補助人工心臓の応用は、医療分野での需要を高め、市場の成長を後押しします。また、補助人工心臓に対する患者や医療従事者の意識の高まりも、市場の成長を後押ししています。
さらに、心血管系疾患とその高度な治療オプションに関する人々の意識を高めるために、政府やその他の組織による取り組みが行われています。たとえば、イングランドの国民保健サービス(NHS)長期計画では、プライマリケアネットワーク(PCN)を通じた地域での心不全の早期発見の促進、集学的チーム(MDT)主導のケアの強化、病院での専門的ケアへの迅速なアクセスに重点を置き、2019年に心不全を優先事項として指定しました。このような様々な組織による啓発プログラムは、補助人工心臓を含む心不全の高度な治療法に関する一般の人々の認識を高めます。これが補助人工心臓(VAD)市場の拡大にさらにつながっています。
さまざまな主要因が市場の成長を促進していますが、補助人工心臓や埋め込みに伴う高額な費用、処置に伴う重大なリスクなどが市場の成長を妨げている要因もあります。このような高価格は、主に発展途上国や低開発国における補助人工心臓へのアクセスに制限をもたらします。さらに、低開発国の人々の間では、心不全の高度な治療法に関する認識が不足していることも、市場成長の阻害要因となっています。さらに、補助人工心臓の植え込みは、手術による血栓や出血を引き起こす可能性があり、感染や装置の誤作動を引き起こす可能性があることも、市場の抑制要因となっています。
一方、主要な市場参入企業は補助人工心臓関連の研究開発活動に大規模な投資を行っています。企業は、既存の補助人工心臓の欠点を克服できる高度な補助人工心臓を開発するための技術革新に注力しています。さらに、補助人工心臓の効率性を証明し、承認を得るために、数多くの臨床研究や開発研究が行われています。このことは、予測期間中の市場拡大を促進すると予想されます。
例えば、2022年10月、Abiomedは、Impella RP Flex with SmartAssistが、最大14日間の急性右心不全の治療に安全かつ有効であるとして、米国食品医薬品局(FDA)の市販前承認(PMA)を取得したと発表しました。このように、これらの製品の承認や発売が増えることは、市場の成長に貢献します。さらに、世界的な心不全の急増、補助人工心臓の新技術の進歩、心臓のモニタリングに関する患者の意識、心臓ドナーの不足などが市場成長の原動力となっています。

補助人工心臓(VAD)市場は、製品、用途、デザイン、年齢、地域によって区分されます。
製品別では、左室補助循環装置(LVAD)、右室補助循環装置(RVAD)、両心室補助循環装置(BIVAD)に分類されます。
用途別では、市場は移植へのブリッジ(BTT)、目的地療法、回復へのブリッジ(BTR)、候補地へのブリッジ療法に細分化されます。
デザイン別では、市場は経皮的補助人工心臓と埋め込み型補助人工心臓に二分されます。
年齢別では、市場は成人と小児に分けられます。
地域別では、北米(米国、カナダ、メキシコ)、欧州(ドイツ、フランス、英国、イタリア、スペイン、その他の欧州地域)、アジア太平洋地域(日本、中国、オーストラリア、インド、韓国、その他のアジア太平洋地域)、LAMEA(ブラジル、南アフリカ、サウジアラビア、その他のLAMEA地域)に市場を分けて分析しています。

世界の補助人工心臓(VAD)市場で事業を展開する主な主要企業は、Abbott Laboratories、Abiomed, Inc.、AdjuCor GmbH、Berlin Heart GmbH、Bivacor Inc.、Calon Cardio-Technology Ltd、Carmat SA、CH Biomedical, Inc.、Corewave SA、Evaheart, Inc.、Fineheart、Jarvik Heart, Inc.、LivaNova PLC、NuPulseCV, Inc.、SynCardia Systems, LLC、Windmill Cardiovascular Systemsなどです。

〈ステークホルダーにとっての主なメリット〉
・(VAD)市場分析の市場セグメント、現在の動向、予測、ダイナミクスを定量的に分析し、補助人工心臓(VAD)市場の有力な機会を特定します。
・主要な促進要因、阻害要因、機会に関する情報とともに市場調査を提供します。
・ポーターのファイブフォース分析により、バイヤーとサプライヤーの潜在力を明らかにし、ステークホルダーが利益重視のビジネス決定を下し、サプライヤーとバイヤーのネットワークを強化できるようにします。
・補助人工心臓(VAD)市場のセグメンテーションを詳細に分析することで、市場機会を見極めることができます。
・各地域の主要国を世界市場への収益貢献度に応じてマッピングしています。
・市場プレイヤーのポジショニングはベンチマーキングを容易にし、市場プレイヤーの現在のポジションを明確に理解することができます。
・地域別および世界の補助人工心臓(VAD)市場動向、主要企業、市場セグメント、応用分野、市場成長戦略の分析を含みます。

〈主要市場セグメント〉
製品別
左心補助循環装置(LVAD)
右室補助循環装置(RVAD)
両心室アシスト装置(BIVAD)

用途別
移植へのブリッジ(BTT)
目的地治療
回復へのブリッジ(BTR)
移植登録へのブリッジブリッジ

デザイン別
経皮的補助人工心臓
植込み型補助人工心臓

年齢別
成人
小児

地域別
・北米
アメリカ
カナダ
メキシコ
・ヨーロッパ
ドイツ
フランス
イギリス
イタリア
スペイン
その他のヨーロッパ
・アジア太平洋
日本
中国
オーストラリア
インド
韓国
その他のアジア太平洋地域
・LAMEA
ブラジル
サウジアラビア
南アフリカ
その他のLAMEA地域

〈主要市場プレイヤー〉
Evaheart, Inc.
Abiomed, Inc.
Abbott Laboratories
CH Biomedical, Inc.
Carmat SA
Calon Cardio-Technology Ltd
Bivacor Inc.
LivaNova PLC
Berlin Heart GmbH
Fineheart
AdjuCor GmbH
NuPulseCV, Inc.
Jarvik Heart, Inc.
SynCardia Systems, LLC
Corewave SA
Windmill Cardiovascular Systems

❖ レポートの目次 ❖

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Bargaining power of suppliers
3.3.2. Bargaining power of buyers
3.3.3. Threat of substitutes
3.3.4. Threat of new entrants
3.3.5. Intensity of rivalry
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Increase in incidence of heart failures
3.4.1.2. Technological advancements
3.4.1.3. Rise in patient awareness about heart failure treatment options
3.4.1.4. Dearth of heart donors

3.4.2. Restraints
3.4.2.1. High cost of devices and procedures
3.4.2.2. Serious risks involved in the procedure

3.4.3. Opportunities
3.4.3.1. Lucrative opportunities in the emerging markets

3.5. COVID-19 Impact Analysis on the market
CHAPTER 4: VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast
4.2. Left Ventricular Assist Devices (LVADs)
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Right Ventricular Assist Devices (RVADs)
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.4. Biventricular Assist Devices (BIVADs)
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
CHAPTER 5: VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Bridge-To-Transplant (BTT)
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Destination Therapy
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Bridge-To-Recovery (BTR)
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
5.5. Bridge To Candidacy Therapy
5.5.1. Key market trends, growth factors and opportunities
5.5.2. Market size and forecast, by region
5.5.3. Market share analysis by country
CHAPTER 6: VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN
6.1. Overview
6.1.1. Market size and forecast
6.2. Transcutaneous Ventricular Assist Devices
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Implantable Ventricular Assist Devices
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
CHAPTER 7: VENTRICULAR ASSIST DEVICES MARKET, BY AGE
7.1. Overview
7.1.1. Market size and forecast
7.2. Adults
7.2.1. Key market trends, growth factors and opportunities
7.2.2. Market size and forecast, by region
7.2.3. Market share analysis by country
7.3. Pediatrics
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Market size and forecast, by region
7.3.3. Market share analysis by country
CHAPTER 8: VENTRICULAR ASSIST DEVICES MARKET, BY REGION
8.1. Overview
8.1.1. Market size and forecast By Region
8.2. North America
8.2.1. Key trends and opportunities
8.2.2. Market size and forecast, by Product
8.2.3. Market size and forecast, by Application
8.2.4. Market size and forecast, by Design
8.2.5. Market size and forecast, by Age
8.2.6. Market size and forecast, by country
8.2.6.1. U.S.
8.2.6.1.1. Key market trends, growth factors and opportunities
8.2.6.1.2. Market size and forecast, by Product
8.2.6.1.3. Market size and forecast, by Application
8.2.6.1.4. Market size and forecast, by Design
8.2.6.1.5. Market size and forecast, by Age
8.2.6.2. Canada
8.2.6.2.1. Key market trends, growth factors and opportunities
8.2.6.2.2. Market size and forecast, by Product
8.2.6.2.3. Market size and forecast, by Application
8.2.6.2.4. Market size and forecast, by Design
8.2.6.2.5. Market size and forecast, by Age
8.2.6.3. Mexico
8.2.6.3.1. Key market trends, growth factors and opportunities
8.2.6.3.2. Market size and forecast, by Product
8.2.6.3.3. Market size and forecast, by Application
8.2.6.3.4. Market size and forecast, by Design
8.2.6.3.5. Market size and forecast, by Age
8.3. Europe
8.3.1. Key trends and opportunities
8.3.2. Market size and forecast, by Product
8.3.3. Market size and forecast, by Application
8.3.4. Market size and forecast, by Design
8.3.5. Market size and forecast, by Age
8.3.6. Market size and forecast, by country
8.3.6.1. Germany
8.3.6.1.1. Key market trends, growth factors and opportunities
8.3.6.1.2. Market size and forecast, by Product
8.3.6.1.3. Market size and forecast, by Application
8.3.6.1.4. Market size and forecast, by Design
8.3.6.1.5. Market size and forecast, by Age
8.3.6.2. France
8.3.6.2.1. Key market trends, growth factors and opportunities
8.3.6.2.2. Market size and forecast, by Product
8.3.6.2.3. Market size and forecast, by Application
8.3.6.2.4. Market size and forecast, by Design
8.3.6.2.5. Market size and forecast, by Age
8.3.6.3. UK
8.3.6.3.1. Key market trends, growth factors and opportunities
8.3.6.3.2. Market size and forecast, by Product
8.3.6.3.3. Market size and forecast, by Application
8.3.6.3.4. Market size and forecast, by Design
8.3.6.3.5. Market size and forecast, by Age
8.3.6.4. Italy
8.3.6.4.1. Key market trends, growth factors and opportunities
8.3.6.4.2. Market size and forecast, by Product
8.3.6.4.3. Market size and forecast, by Application
8.3.6.4.4. Market size and forecast, by Design
8.3.6.4.5. Market size and forecast, by Age
8.3.6.5. Spain
8.3.6.5.1. Key market trends, growth factors and opportunities
8.3.6.5.2. Market size and forecast, by Product
8.3.6.5.3. Market size and forecast, by Application
8.3.6.5.4. Market size and forecast, by Design
8.3.6.5.5. Market size and forecast, by Age
8.3.6.6. Rest of Europe
8.3.6.6.1. Key market trends, growth factors and opportunities
8.3.6.6.2. Market size and forecast, by Product
8.3.6.6.3. Market size and forecast, by Application
8.3.6.6.4. Market size and forecast, by Design
8.3.6.6.5. Market size and forecast, by Age
8.4. Asia-Pacific
8.4.1. Key trends and opportunities
8.4.2. Market size and forecast, by Product
8.4.3. Market size and forecast, by Application
8.4.4. Market size and forecast, by Design
8.4.5. Market size and forecast, by Age
8.4.6. Market size and forecast, by country
8.4.6.1. Japan
8.4.6.1.1. Key market trends, growth factors and opportunities
8.4.6.1.2. Market size and forecast, by Product
8.4.6.1.3. Market size and forecast, by Application
8.4.6.1.4. Market size and forecast, by Design
8.4.6.1.5. Market size and forecast, by Age
8.4.6.2. China
8.4.6.2.1. Key market trends, growth factors and opportunities
8.4.6.2.2. Market size and forecast, by Product
8.4.6.2.3. Market size and forecast, by Application
8.4.6.2.4. Market size and forecast, by Design
8.4.6.2.5. Market size and forecast, by Age
8.4.6.3. Australia
8.4.6.3.1. Key market trends, growth factors and opportunities
8.4.6.3.2. Market size and forecast, by Product
8.4.6.3.3. Market size and forecast, by Application
8.4.6.3.4. Market size and forecast, by Design
8.4.6.3.5. Market size and forecast, by Age
8.4.6.4. India
8.4.6.4.1. Key market trends, growth factors and opportunities
8.4.6.4.2. Market size and forecast, by Product
8.4.6.4.3. Market size and forecast, by Application
8.4.6.4.4. Market size and forecast, by Design
8.4.6.4.5. Market size and forecast, by Age
8.4.6.5. South Korea
8.4.6.5.1. Key market trends, growth factors and opportunities
8.4.6.5.2. Market size and forecast, by Product
8.4.6.5.3. Market size and forecast, by Application
8.4.6.5.4. Market size and forecast, by Design
8.4.6.5.5. Market size and forecast, by Age
8.4.6.6. Rest of Asia-Pacific
8.4.6.6.1. Key market trends, growth factors and opportunities
8.4.6.6.2. Market size and forecast, by Product
8.4.6.6.3. Market size and forecast, by Application
8.4.6.6.4. Market size and forecast, by Design
8.4.6.6.5. Market size and forecast, by Age
8.5. LAMEA
8.5.1. Key trends and opportunities
8.5.2. Market size and forecast, by Product
8.5.3. Market size and forecast, by Application
8.5.4. Market size and forecast, by Design
8.5.5. Market size and forecast, by Age
8.5.6. Market size and forecast, by country
8.5.6.1. Brazil
8.5.6.1.1. Key market trends, growth factors and opportunities
8.5.6.1.2. Market size and forecast, by Product
8.5.6.1.3. Market size and forecast, by Application
8.5.6.1.4. Market size and forecast, by Design
8.5.6.1.5. Market size and forecast, by Age
8.5.6.2. Saudi Arabia
8.5.6.2.1. Key market trends, growth factors and opportunities
8.5.6.2.2. Market size and forecast, by Product
8.5.6.2.3. Market size and forecast, by Application
8.5.6.2.4. Market size and forecast, by Design
8.5.6.2.5. Market size and forecast, by Age
8.5.6.3. South Africa
8.5.6.3.1. Key market trends, growth factors and opportunities
8.5.6.3.2. Market size and forecast, by Product
8.5.6.3.3. Market size and forecast, by Application
8.5.6.3.4. Market size and forecast, by Design
8.5.6.3.5. Market size and forecast, by Age
8.5.6.4. Rest of LAMEA
8.5.6.4.1. Key market trends, growth factors and opportunities
8.5.6.4.2. Market size and forecast, by Product
8.5.6.4.3. Market size and forecast, by Application
8.5.6.4.4. Market size and forecast, by Design
8.5.6.4.5. Market size and forecast, by Age
CHAPTER 9: COMPETITIVE LANDSCAPE
9.1. Introduction
9.2. Top winning strategies
9.3. Product Mapping of Top 10 Player
9.4. Competitive Dashboard
9.5. Competitive Heatmap
9.6. Top player positioning, 2021
CHAPTER 10: COMPANY PROFILES
10.1. Evaheart, Inc.
10.1.1. Company overview
10.1.2. Key Executives
10.1.3. Company snapshot
10.1.4. Operating business segments
10.1.5. Product portfolio
10.1.6. Key strategic moves and developments
10.2. Calon Cardio-Technology Ltd
10.2.1. Company overview
10.2.2. Key Executives
10.2.3. Company snapshot
10.2.4. Operating business segments
10.2.5. Product portfolio
10.3. Carmat SA
10.3.1. Company overview
10.3.2. Key Executives
10.3.3. Company snapshot
10.3.4. Operating business segments
10.3.5. Product portfolio
10.3.6. Key strategic moves and developments
10.4. Fineheart
10.4.1. Company overview
10.4.2. Key Executives
10.4.3. Company snapshot
10.4.4. Operating business segments
10.4.5. Product portfolio
10.4.6. Key strategic moves and developments
10.5. AdjuCor GmbH
10.5.1. Company overview
10.5.2. Key Executives
10.5.3. Company snapshot
10.5.4. Operating business segments
10.5.5. Product portfolio
10.6. Corewave SA
10.6.1. Company overview
10.6.2. Key Executives
10.6.3. Company snapshot
10.6.4. Operating business segments
10.6.5. Product portfolio
10.6.6. Key strategic moves and developments
10.7. Bivacor Inc.
10.7.1. Company overview
10.7.2. Key Executives
10.7.3. Company snapshot
10.7.4. Operating business segments
10.7.5. Product portfolio
10.7.6. Key strategic moves and developments
10.8. Windmill Cardiovascular Systems
10.8.1. Company overview
10.8.2. Key Executives
10.8.3. Company snapshot
10.8.4. Operating business segments
10.8.5. Product portfolio
10.9. NuPulseCV, Inc.
10.9.1. Company overview
10.9.2. Key Executives
10.9.3. Company snapshot
10.9.4. Operating business segments
10.9.5. Product portfolio
10.10. Abiomed, Inc.
10.10.1. Company overview
10.10.2. Key Executives
10.10.3. Company snapshot
10.10.4. Operating business segments
10.10.5. Product portfolio
10.10.6. Business performance
10.10.7. Key strategic moves and developments
10.11. LivaNova PLC
10.11.1. Company overview
10.11.2. Key Executives
10.11.3. Company snapshot
10.11.4. Operating business segments
10.11.5. Product portfolio
10.11.6. Business performance
10.11.7. Key strategic moves and developments
10.12. Berlin Heart GmbH
10.12.1. Company overview
10.12.2. Key Executives
10.12.3. Company snapshot
10.12.4. Operating business segments
10.12.5. Product portfolio
10.12.6. Key strategic moves and developments
10.13. Jarvik Heart, Inc.
10.13.1. Company overview
10.13.2. Key Executives
10.13.3. Company snapshot
10.13.4. Operating business segments
10.13.5. Product portfolio
10.14. Abbott Laboratories
10.14.1. Company overview
10.14.2. Key Executives
10.14.3. Company snapshot
10.14.4. Operating business segments
10.14.5. Product portfolio
10.14.6. Business performance
10.14.7. Key strategic moves and developments
10.15. SynCardia Systems, LLC
10.15.1. Company overview
10.15.2. Key Executives
10.15.3. Company snapshot
10.15.4. Operating business segments
10.15.5. Product portfolio
10.15.6. Key strategic moves and developments
10.16. CH Biomedical, Inc.
10.16.1. Company overview
10.16.2. Key Executives
10.16.3. Company snapshot
10.16.4. Operating business segments
10.16.5. Product portfolio
10.16.6. Key strategic moves and developments

LIST OF TABLES
TABLE 01. GLOBAL VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 02. VENTRICULAR ASSIST DEVICES MARKET FOR LEFT VENTRICULAR ASSIST DEVICES (LVADS), BY REGION, 2021-2031 ($MILLION)
TABLE 03. VENTRICULAR ASSIST DEVICES MARKET FOR RIGHT VENTRICULAR ASSIST DEVICES (RVADS), BY REGION, 2021-2031 ($MILLION)
TABLE 04. VENTRICULAR ASSIST DEVICES MARKET FOR BIVENTRICULAR ASSIST DEVICES (BIVADS), BY REGION, 2021-2031 ($MILLION)
TABLE 05. GLOBAL VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 06. VENTRICULAR ASSIST DEVICES MARKET FOR BRIDGE-TO-TRANSPLANT (BTT), BY REGION, 2021-2031 ($MILLION)
TABLE 07. VENTRICULAR ASSIST DEVICES MARKET FOR DESTINATION THERAPY, BY REGION, 2021-2031 ($MILLION)
TABLE 08. VENTRICULAR ASSIST DEVICES MARKET FOR BRIDGE-TO-RECOVERY (BTR), BY REGION, 2021-2031 ($MILLION)
TABLE 09. VENTRICULAR ASSIST DEVICES MARKET FOR BRIDGE TO CANDIDACY THERAPY, BY REGION, 2021-2031 ($MILLION)
TABLE 10. GLOBAL VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
TABLE 11. VENTRICULAR ASSIST DEVICES MARKET FOR TRANSCUTANEOUS VENTRICULAR ASSIST DEVICES, BY REGION, 2021-2031 ($MILLION)
TABLE 12. VENTRICULAR ASSIST DEVICES MARKET FOR IMPLANTABLE VENTRICULAR ASSIST DEVICES, BY REGION, 2021-2031 ($MILLION)
TABLE 13. GLOBAL VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
TABLE 14. VENTRICULAR ASSIST DEVICES MARKET FOR ADULTS, BY REGION, 2021-2031 ($MILLION)
TABLE 15. VENTRICULAR ASSIST DEVICES MARKET FOR PEDIATRICS, BY REGION, 2021-2031 ($MILLION)
TABLE 16. VENTRICULAR ASSIST DEVICES MARKET, BY REGION, 2021-2031 ($MILLION)
TABLE 17. NORTH AMERICA VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 18. NORTH AMERICA VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 19. NORTH AMERICA VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
TABLE 20. NORTH AMERICA VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
TABLE 21. NORTH AMERICA VENTRICULAR ASSIST DEVICES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 22. U.S. VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 23. U.S. VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 24. U.S. VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
TABLE 25. U.S. VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
TABLE 26. CANADA VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 27. CANADA VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 28. CANADA VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
TABLE 29. CANADA VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
TABLE 30. MEXICO VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 31. MEXICO VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 32. MEXICO VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
TABLE 33. MEXICO VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
TABLE 34. EUROPE VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 35. EUROPE VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 36. EUROPE VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
TABLE 37. EUROPE VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
TABLE 38. EUROPE VENTRICULAR ASSIST DEVICES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 39. GERMANY VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 40. GERMANY VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 41. GERMANY VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
TABLE 42. GERMANY VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
TABLE 43. FRANCE VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 44. FRANCE VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 45. FRANCE VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
TABLE 46. FRANCE VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
TABLE 47. UK VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 48. UK VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 49. UK VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
TABLE 50. UK VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
TABLE 51. ITALY VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 52. ITALY VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 53. ITALY VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
TABLE 54. ITALY VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
TABLE 55. SPAIN VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 56. SPAIN VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 57. SPAIN VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
TABLE 58. SPAIN VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
TABLE 59. REST OF EUROPE VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 60. REST OF EUROPE VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 61. REST OF EUROPE VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
TABLE 62. REST OF EUROPE VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
TABLE 63. ASIA-PACIFIC VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 64. ASIA-PACIFIC VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 65. ASIA-PACIFIC VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
TABLE 66. ASIA-PACIFIC VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
TABLE 67. ASIA-PACIFIC VENTRICULAR ASSIST DEVICES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 68. JAPAN VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 69. JAPAN VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 70. JAPAN VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
TABLE 71. JAPAN VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
TABLE 72. CHINA VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 73. CHINA VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 74. CHINA VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
TABLE 75. CHINA VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
TABLE 76. AUSTRALIA VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 77. AUSTRALIA VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 78. AUSTRALIA VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
TABLE 79. AUSTRALIA VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
TABLE 80. INDIA VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 81. INDIA VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 82. INDIA VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
TABLE 83. INDIA VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
TABLE 84. SOUTH KOREA VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 85. SOUTH KOREA VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 86. SOUTH KOREA VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
TABLE 87. SOUTH KOREA VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
TABLE 88. REST OF ASIA-PACIFIC VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 89. REST OF ASIA-PACIFIC VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 90. REST OF ASIA-PACIFIC VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
TABLE 91. REST OF ASIA-PACIFIC VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
TABLE 92. LAMEA VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 93. LAMEA VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 94. LAMEA VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
TABLE 95. LAMEA VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
TABLE 96. LAMEA VENTRICULAR ASSIST DEVICES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 97. BRAZIL VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 98. BRAZIL VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 99. BRAZIL VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
TABLE 100. BRAZIL VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
TABLE 101. SAUDI ARABIA VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 102. SAUDI ARABIA VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 103. SAUDI ARABIA VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
TABLE 104. SAUDI ARABIA VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
TABLE 105. SOUTH AFRICA VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 106. SOUTH AFRICA VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 107. SOUTH AFRICA VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
TABLE 108. SOUTH AFRICA VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
TABLE 109. REST OF LAMEA VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 110. REST OF LAMEA VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 111. REST OF LAMEA VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
TABLE 112. REST OF LAMEA VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
TABLE 113. EVAHEART, INC.: KEY EXECUTIVES
TABLE 114. EVAHEART, INC.: COMPANY SNAPSHOT
TABLE 115. EVAHEART, INC.: PRODUCT SEGMENTS
TABLE 116. EVAHEART, INC.: PRODUCT PORTFOLIO
TABLE 117. EVAHEART, INC.: KEY STRATERGIES
TABLE 118. CALON CARDIO-TECHNOLOGY LTD: KEY EXECUTIVES
TABLE 119. CALON CARDIO-TECHNOLOGY LTD: COMPANY SNAPSHOT
TABLE 120. CALON CARDIO-TECHNOLOGY LTD: PRODUCT SEGMENTS
TABLE 121. CALON CARDIO-TECHNOLOGY LTD: PRODUCT PORTFOLIO
TABLE 122. CARMAT SA: KEY EXECUTIVES
TABLE 123. CARMAT SA: COMPANY SNAPSHOT
TABLE 124. CARMAT SA: PRODUCT SEGMENTS
TABLE 125. CARMAT SA: PRODUCT PORTFOLIO
TABLE 126. CARMAT SA: KEY STRATERGIES
TABLE 127. FINEHEART: KEY EXECUTIVES
TABLE 128. FINEHEART: COMPANY SNAPSHOT
TABLE 129. FINEHEART: PRODUCT SEGMENTS
TABLE 130. FINEHEART: PRODUCT PORTFOLIO
TABLE 131. FINEHEART: KEY STRATERGIES
TABLE 132. ADJUCOR GMBH: KEY EXECUTIVES
TABLE 133. ADJUCOR GMBH: COMPANY SNAPSHOT
TABLE 134. ADJUCOR GMBH: PRODUCT SEGMENTS
TABLE 135. ADJUCOR GMBH: PRODUCT PORTFOLIO
TABLE 136. COREWAVE SA: KEY EXECUTIVES
TABLE 137. COREWAVE SA: COMPANY SNAPSHOT
TABLE 138. COREWAVE SA: PRODUCT SEGMENTS
TABLE 139. COREWAVE SA: PRODUCT PORTFOLIO
TABLE 140. COREWAVE SA: KEY STRATERGIES
TABLE 141. BIVACOR INC.: KEY EXECUTIVES
TABLE 142. BIVACOR INC.: COMPANY SNAPSHOT
TABLE 143. BIVACOR INC.: PRODUCT SEGMENTS
TABLE 144. BIVACOR INC.: PRODUCT PORTFOLIO
TABLE 145. BIVACOR INC.: KEY STRATERGIES
TABLE 146. WINDMILL CARDIOVASCULAR SYSTEMS: KEY EXECUTIVES
TABLE 147. WINDMILL CARDIOVASCULAR SYSTEMS: COMPANY SNAPSHOT
TABLE 148. WINDMILL CARDIOVASCULAR SYSTEMS: PRODUCT SEGMENTS
TABLE 149. WINDMILL CARDIOVASCULAR SYSTEMS: PRODUCT PORTFOLIO
TABLE 150. NUPULSECV, INC.: KEY EXECUTIVES
TABLE 151. NUPULSECV, INC.: COMPANY SNAPSHOT
TABLE 152. NUPULSECV, INC.: PRODUCT SEGMENTS
TABLE 153. NUPULSECV, INC.: PRODUCT PORTFOLIO
TABLE 154. ABIOMED, INC.: KEY EXECUTIVES
TABLE 155. ABIOMED, INC.: COMPANY SNAPSHOT
TABLE 156. ABIOMED, INC.: PRODUCT SEGMENTS
TABLE 157. ABIOMED, INC.: PRODUCT PORTFOLIO
TABLE 158. ABIOMED, INC.: KEY STRATERGIES
TABLE 159. LIVANOVA PLC: KEY EXECUTIVES
TABLE 160. LIVANOVA PLC: COMPANY SNAPSHOT
TABLE 161. LIVANOVA PLC: PRODUCT SEGMENTS
TABLE 162. LIVANOVA PLC: PRODUCT PORTFOLIO
TABLE 163. LIVANOVA PLC: KEY STRATERGIES
TABLE 164. BERLIN HEART GMBH: KEY EXECUTIVES
TABLE 165. BERLIN HEART GMBH: COMPANY SNAPSHOT
TABLE 166. BERLIN HEART GMBH: PRODUCT SEGMENTS
TABLE 167. BERLIN HEART GMBH: PRODUCT PORTFOLIO
TABLE 168. BERLIN HEART GMBH: KEY STRATERGIES
TABLE 169. JARVIK HEART, INC.: KEY EXECUTIVES
TABLE 170. JARVIK HEART, INC.: COMPANY SNAPSHOT
TABLE 171. JARVIK HEART, INC.: PRODUCT SEGMENTS
TABLE 172. JARVIK HEART, INC.: PRODUCT PORTFOLIO
TABLE 173. ABBOTT LABORATORIES: KEY EXECUTIVES
TABLE 174. ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 175. ABBOTT LABORATORIES: PRODUCT SEGMENTS
TABLE 176. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 177. ABBOTT LABORATORIES: KEY STRATERGIES
TABLE 178. SYNCARDIA SYSTEMS, LLC: KEY EXECUTIVES
TABLE 179. SYNCARDIA SYSTEMS, LLC: COMPANY SNAPSHOT
TABLE 180. SYNCARDIA SYSTEMS, LLC: PRODUCT SEGMENTS
TABLE 181. SYNCARDIA SYSTEMS, LLC: PRODUCT PORTFOLIO
TABLE 182. SYNCARDIA SYSTEMS, LLC: KEY STRATERGIES
TABLE 183. CH BIOMEDICAL, INC.: KEY EXECUTIVES
TABLE 184. CH BIOMEDICAL, INC.: COMPANY SNAPSHOT
TABLE 185. CH BIOMEDICAL, INC.: PRODUCT SEGMENTS
TABLE 186. CH BIOMEDICAL, INC.: PRODUCT PORTFOLIO
TABLE 187. CH BIOMEDICAL, INC.: KEY STRATERGIES

★調査レポート[世界の補助人工心臓(VAD)市場2021年-2031年:製品別(左心室補助装置(LVAD)、右心室補助装置(RVAD)、両室節補助装置(BIVAD))、用途別(移植へのブリッジ(BTT)、長期在宅補助人工心臓治療(DT)、回復へのブリッジ(BTR)、移植登録へのブリッジ(BTC)療法)、デザイン別(経皮的補助人工心臓、埋め込み可能型補助人工心臓)、年齢別(成人、小児科)] (コード:ALD23MY043)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の補助人工心臓(VAD)市場2021年-2031年:製品別(左心室補助装置(LVAD)、右心室補助装置(RVAD)、両室節補助装置(BIVAD))、用途別(移植へのブリッジ(BTT)、長期在宅補助人工心臓治療(DT)、回復へのブリッジ(BTR)、移植登録へのブリッジ(BTC)療法)、デザイン別(経皮的補助人工心臓、埋め込み可能型補助人工心臓)、年齢別(成人、小児科)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆